A retrospective study of the efficacy of zonisamide in controlling seizures in cats
Evidence-based recommendations for antiepileptic drug selection in cats beyond phenobarbital are limited, and additional studies are needed for cats where seizures remain inadequately controlled by administration of phenobarbital alone or for cats that cannot safely receive phenobarbital. The objective of this study was to compare seizure frequency in cats before and after oral administration of zonisamide and describe adverse clinical or clinicopathologic effects in this cohort.
Median number of seizures per month and number of seizure days per month were compared before and after administration of zonisamide in all cats, a subgroup of cats with idiopathic epilepsy (IE), and a subgroup of cats receiving zonisamide as sole therapy. Clinical and clinicopathologic adverse effect data were also reported.
Fifty-seven cats with a history of seizures were enrolled. A median decrease of 1 (P = .001, 95% confidence interval (CI) [-1.0, -0.5]) seizure per month, and 1 (P = .003, 95% CI [-1.5, -0.2]) seizure days per month was found across all cats after oral administration of zonisamide. The subgroup with IE showed median decreases of 1 (P = .03, 95% CI [-2.0, -0.5]) and 2 (P = .01, 95% CI [-2.5, -1.0]), respectively. The most common clinical adverse effects were sedation (17%), ataxia (11%), hyporexia (17%), and emesis (5%). One cat developed mild nonregenerative anemia, 2 cats developed mild metabolic acidosis, and 6 cats showed mild increases in ALT and ALP.
Finally, zonisamide was well tolerated and efficacious in controlling seizure activity in most cats and it can be used as an alternative or an adjunct therapy to phenobarbital or levetiracetam for seizure control in cats.
“A retrospective study of the efficacy of zonisamide in controlling seizures in 57 cats”. Dylan M Djani, et al. J Vet Intern Med. 2024 Jan 19. doi: 10.1111/jvim.16984.
Source: https://onlinelibrary.wiley.com/doi/full/10.1111/jvim.16984
Comments
Related Articles
More news
Copyright © 2025 - All Rights Reserved
ISSN 2768-198X
List
Add
Please enter a comment